Benzodiazepine Avoidance

Benzodiazepine Avoidance is a clinical pharmacotherapy principle that mandates the systematic exclusion of benzodiazepines in the management of delirium due to their association with worsened neurocognitive outcomes, distinguishing it from other sedative strategies that may prioritize receptor agonism without accounting for delirium-specific risks.

9

Publications

177

Citations

51

Authors

21

Institutions

Publications per year

2017–2026

4

Authors

51

  1. JS
    Jessica Spence

    McMaster University, Canada

    2 publications · 49 citations

    2

    h-index

  2. EP
    Emilie P. Belley‐Côté

    McMaster University, Canada

    2 publications · 49 citations

    2

    h-index

  3. SK
    Sachin Kheterpal

    University of Michigan, United States

    1 publications · 21 citations

    1

    h-index

  4. EJ
    Eric Jacobsohn

    University of Manitoba, Canada

    1 publications · 28 citations

    1

    h-index

  5. PV
    Patrice Venault

    Centre National de la Recherche Scientifique, France

    1 publications · 13 citations

    1

    h-index

1–5 of 51

Venues

  1. British Journal of Anaesthesia

    2 publications · 49 citations

    2

    h-index

  2. PubMed

    Repository · 2 publications · 45 citations

    2

    h-index

  3. Psychobiology

    1 publications · 13 citations

    1

    h-index

  4. Psychopharmacology

    1 publications · 26 citations

    1

    h-index

  5. BMC Anesthesiology

    1 publications · 12 citations

    1

    h-index

1–5